mdh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
An Analysis of a Changing Society and its Impact on Pharmaceutical Companies’ Supply Chain Management
Mälardalen University, School of Business, Society and Engineering.
Mälardalen University, School of Business, Society and Engineering.
Mälardalen University, School of Business, Society and Engineering.
2018 (English)Independent thesis Basic level (degree of Bachelor), 10 credits / 15 HE creditsStudent thesis
Abstract [en]

Abstract

Date: 2018-06-03

Level: Bachelor thesis in Business Administration, 15 ECTS

Institution: School of Business, Society and Engineering, Mälardalen University

Authors: Filip Altblom György Simon Pálfi Johanna Åhlander

(96/11/14) (83/11/02) (96/07/24)

Title: An Analysis of a Changing Society and its Impact on a Pharmaceutical

Company’s Supply Chain Management

Supervisor: Edward Gillmore

Keywords: supply chain management, pharmaceutical industry, AstraZeneca,

context, strategic decisions

Research

Question: How does the pharmaceutical companies’ context affect their supply chain

management?

Purpose: The purpose of this bachelor thesis is to examine different changes within the context

of the pharmaceutical industry and how these changes affect companies’ supply

chain management.

Method: To investigate the research question of this thesis, the data collected was of secondary

nature and was gathered from governmental authorities, scientific articles, annual

reports, press releases and newspapers. The secondary data was used to achieve a

broad view of the investigated subject and to interpret, analyse and make an objective

conclusion regarding the research question of this thesis.

Conclusion: The conclusion of this thesis is that the analysed context forces AstraZeneca to

modify the strategy of their supply chain. This in order to maximize their profit and

performance and to reduce the risk of a market loss and/or eventually a shortage of

supply, compared to the increasing demand of medicine and treatment. It could be

argued that this goes for all market leading pharmaceutical companies since this

context most likely affect every company within the industry.

Place, publisher, year, edition, pages
2018. , p. 49
National Category
Business Administration
Identifiers
URN: urn:nbn:se:mdh:diva-39452OAI: oai:DiVA.org:mdh-39452DiVA, id: diva2:1212711
Supervisors
Examiners
Available from: 2018-06-14 Created: 2018-06-03 Last updated: 2018-06-14Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
School of Business, Society and Engineering
Business Administration

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 13 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf